Similar articles

• Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.

  Malla A, Mustafa S, Rho A, Abadi S, Lepage M, Joober R. Malla A, et al. Schizophr Res. 2016 Jul;174(1-3):120-125. doi: 10.1016/j.schres.2016.04.036. Epub 2016 May 4. Schizophr Res. 2016. PMID: 27157800
• Corrigendum to "abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].

  Alvarado-Alanis P, León-Ortiz P, Reyes-Madrigal F, Favila R, Rodríguez-Mayoral O, Nicolini H, Azcárraga M, Graff-Guerrero A, Rowland LM, de la Fuente-Sandoval C. Alvarado-Alanis P, et al. Schizophr Res. 2016 Oct;176(2-3):582. doi: 10.1016/j.schres.2016.05.025. Epub 2016 Jun 2. Schizophr Res. 2016. PMID: 27264503 No abstract available.
• Corrigendum to "Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study" [Schizophr. Res. volume 225 (May 2023) 173-181].

  Millgate E, Smart SE, Pardiñas AF, Kravariti E, Ajnakina O, Kępińska AP, Andreassen OA, Barnes TRE, Berardi D, Crespo-Facorro B, D'Andrea G, Demjaha A, Di Forti M, Doody GA, Üçok A, Kassoumeri L, Ferchiou A, Guidi L, Joyce EM, Lastrina O, Melle I, Pignon B, Richard JR, Simonsen C, Szöke A, Tarricone I, Tortelli A, Vázquez-Bourgon J, Murray RM, Walters JTR, MacCabe JH; STRATA Consortium. Millgate E, et al. Schizophr Res. 2024 Aug;270:495-496. doi: 10.1016/j.schres.2024.06.029. Epub 2024 Jul 29. Schizophr Res. 2024. PMID: 39079354 Free PMC article. No abstract available.
• Clinical effectiveness in first-episode patients.

  Ohlsen RI, O'Toole MS, Purvis RG, Walters JT, Taylor TM, Jones HM, Pilowsky LS. Ohlsen RI, et al. Eur Neuropsychopharmacol. 2004 Nov;14 Suppl 4:S445-51. doi: 10.1016/j.euroneuro.2004.08.003. Eur Neuropsychopharmacol. 2004. PMID: 15572263 Review.
• Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.

  Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, Wood SJ, Berk M, McGorry PD. Francey SM, et al. Schizophr Res. 2010 Jun;119(1-3):1-10. doi: 10.1016/j.schres.2010.02.1071. Epub 2010 Mar 26. Schizophr Res. 2010. PMID: 20347270 Review.